Member Info for Laura2022

Suggest a breakout from here ...according to telegram it is 0.9p to take a big move

Yes Barno

This was 1p and 4p last month and 10p+ early in 2024

PYC VRS moving too

Another brilliant summary from long term holder KingH

PYC has started the new financial year with the highest revenue on the books £600k VS MC???? undervalued.

it has also created a new division in bio stats for revenue generation.

the key thing that naturally has taken around 8 years for development is the Prostate Cancer dosing app, which has been supported and funded by CRUK & NIHR and has a colab with DOSEMERX which is a global software company - this is currently at a trial with Beyond Blood and also NHS. After many years in the waiting we are getting to the commercialisation point which would be and should be hugely significant.

Dosemerx charges 2.5k per license and has 100,000 of licenses globally.

Medical devises do take time naturally to develop as you can probably appreciate - think of it a bit similar to Oil Company it takes years even decades from discovery to production.

There is also a up to £6mil due if Val ever gets the 201 deal over the line.

over the last ten years LTH have made considerable amounts of money by top slicing then reinvesting as PYC has a history of having great runs - see charts ----0.50p to 30p ---2p to 20p ---1p to 15p ---1.3p to 18p

with the new CEO in place, the dosing tool update due, £6m potential from Val, funded, record revenues, more contracts due, new revenue stream at this MC it is significantly undervalued.

hope this helps

And still the buys pour in

This Thurs and next Thurs are the key dates ...this Thurs GM

Those other 2 shares are moving now Acklee

Https://www.lse.co.uk/rns/VRS/holdings-in-company-uqufdv7uk2eall2.html

Who is JJ?

The Jones on the TR1 has 236mln shares and has bought more as contained in the Tr1

Buying continues but no quote to buy on HL

£57k

Showing

Bobat

You've sold your imaginary shares in Cgh and upl to buy upl do why ar you here ?

Yes Aklee

And even if they win vote.on 8th they (imho) will start to purchase more shares on open market as happened DEST

Shows the value potential for PYCs business going forward

GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a provider of integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. GE HealthCare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease-of-use for the benefit of clinicians and patients.

"We are pleased to bring innovative technology from Intelligent Ultrasound into GE HealthCare’s Ultrasound portfolio, allowing us to fully integrate these solutions into our systems to help clinicians improve workflow, reduce repetitive tasks, and simplify exams,” s

Well done GB and no problem..at 0.65/£1.2mln cap PYC will motor

Works with some largest pharma companies and other A.I software medical tools been sold for £40mln recently ..PYC have one being endorsed in USA for cancer

Research papers with Big pharms that will be published....

Comparable Vs other companies in MC whom have millions in losses which are x10 our MC

Dosing Application Approval process - both EU and US (both seem to be in process)

New Contracts

NHS potential rollout via CRUK

Bicycle Therapeutics news due... and research publication in September

The fact multi multi companies are endorsing PYC for there efficiency, data driven tech saving them Millions £££

This person just trolls (see his posting history)

Good point regarding beyond blood, clearly someone took the placing

I did that here and DEST and have been adding over last 2 weeks to VRS PYC

Buy when others are fearful I believe is the phrase

Certainly looking good

Not a problem

Was always risky but I did the research and seemed something at play

What are NOT high risk are VRS and PYC as both funded, amd revenue generating tech stocks which have done 100-500% moves

That's DEST and CGH where I've seen a 100% + rise

I think small caps VRS (graphene) and PYC (A.I drug development software) who are both fully funded now will do similar